Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Biotools
  • Published:

Recombinant Conception: Does It Require the DNA?

Bio/Technology volume 11, pages 1306–1307 (1993)Cite this article

Abstract

Do recent Federal Cirucit Court decisions mandate cloning a gene in order to get patent protection?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Amgen, Inc. v Chugai, 18 U.S.P.Q.2d, 1016 (Fed Cir., 1991).

  2. Fiers v. Sugano, 25 U.S.P.Q.2d, 1601 (Fed Cir., 1993).

  3. 18 U.S.P.Q.2dat 1021.

  4. 25 U.S.P.Q.2d at 1604-1605.

Download references

Author information

Author notes

  1. Richard J. Warburg: The opinions expressed here are soley those of the author and not Lyon and Lyon.

Authors and Affiliations

  1. Ph. D., is a patent attorney at Lyon and Lyon, San Diego, CA

    Richard J. Warburg

Authors
  1. Richard J. Warburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warburg, R. Recombinant Conception: Does It Require the DNA?. Nat Biotechnol 11, 1306–1307 (1993). https://doi.org/10.1038/nbt1193-1306

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1193-1306

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing